Amsacrine
Back to searchMolecule Structure
Scientific Name
Amsacrine
Description of the Drug
Amsacrine is a cytotoxic agent used to induce remission in acute adult leukemia that is not adequately responsive to other agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00276
http://www.drugbank.ca/drugs/DB00276
Brand Name(s)
Amsidyl
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA topoisomerase II | PROTEIN FAMILY | INHIBITOR | CHEMBL2094255 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4047 | ||||
| PharmGKB | PA10309 | ||||
| Human Metabolome Database | HMDB0014421 | ||||
| DrugBank | DB00276 | ||||
| PubChem: Thomson Pharma | 14927834 | ||||
| PubChem | 2179 | ||||
| NMRShiftDB | 80016497 | ||||
| LINCS | LSM-45972 | ||||
| Nikkaji | J1.056A | ||||
| PDBe | ASW | ||||
| BindingDB | 87351 | ||||
| EPA CompTox Dashboard | DTXSID4022604 | ||||
| DrugCentral | 203 | ||||
| Brenda | 156093 | 11596 | 57895 | 10836 | 48654 |
| ChemicalBook | CB1236394 | ||||
| rxnorm | AMSACRINE | ||||
| PubChem: Drugs of the Future | 12013305 | ||||
| KEGG Ligand | C01553 | ||||
| ChEBI | 2687 | ||||
| ZINC | ZINC000003812923 |
